Home/Medicines/Bethanechol
All medicines

Bethanechol

Prescription
Parasympathomimetic (cholinergic agonist)
Last reviewed 19 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
2 available
Formulations
3

Mechanism of action

Directly stimulates muscarinic receptors on the detrusor muscle, enhancing bladder contraction; resistant to cholinesterase degradation

At a glance

Class
Parasympathomimetic (cholinergic agonist)
Schedule
Prescription
Storage
Store below 25°C

Dosing

🐕

Dog

Detrusor atony / Urinary retention (non-obstructive)
Dose
2.5–25 mg per dog
Route
PO
Frequency
TID
Max dose
50 mg/dose; 150 mg/day
Duration: As needed; until detrusor tone returns
🐈

Cat

Detrusor atony / Urinary retention (non-obstructive)
Dose
1.25–5 mg per cat
Route
PO
Frequency
TID
Max dose
7.5 mg/dose; 22.5 mg/day
Duration: As needed; until detrusor tone returns

Formulations

💊

Tablet — 3

Strength
5mg
Available in India
Strength
10mg
Available in India
Strength
25mg
Available in India

Storage

Store below 25°C

Safety

Absolute contraindications — do not use

  • Urinary obstruction (mechanical)
    Must rule out obstruction before use
  • GI obstruction

Use with caution

  • Hyperthyroidism
    May exacerbate cardiac effects

Adverse effects

Common
Salivation
Vomiting
Diarrhoea
Abdominal cramping
Serious
Bradycardia
Bronchospasm
Hypotension

Monitoring parameters

Urination patternResidual urine volume (ultrasound)Heart rate

Interactions

No documented interactions.

Brands

International

Urecholine
Merck

India

Urotonin
Sun Pharma

FAQs

Frequently asked questions

What is Bethanechol?
Bethanechol is a parasympathomimetic (cholinergic agonist) used in pets. Directly stimulates muscarinic receptors on the detrusor muscle, enhancing bladder contraction; resistant to cholinesterase degradation
What is Bethanechol used for in pets?
Bethanechol is used in veterinary medicine for: Detrusor atony / Urinary retention (non-obstructive).
What is the Bethanechol dose for dogs?
For dogs, Bethanechol is typically dosed as follows — Detrusor atony / Urinary retention (non-obstructive): 2.5–25 mg per dog PO TID. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What is the Bethanechol dose for cats?
For cats, Bethanechol is typically dosed as follows — Detrusor atony / Urinary retention (non-obstructive): 1.25–5 mg per cat PO TID. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What are the side effects of Bethanechol?
Common: Salivation, Vomiting, Diarrhoea, Abdominal cramping. Serious (call your vet immediately): Bradycardia, Bronchospasm, Hypotension.
Does Bethanechol need a prescription?
Yes. Bethanechol is a prescription medication and should only be administered under veterinary supervision.
When should Bethanechol not be used?
Do not use Bethanechol if: Urinary obstruction (mechanical); GI obstruction.

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →